Aug. 22, 2018:
12 prestigious cancer centers.
2,600 cancer researchers.
1 mission.
In this month’s edition of Across the Consortium, we highlight the many ways our top-ranking members are pushing the boundaries of science and technology in order to improve diagnosis and treatment for all patients with cancer.
August 1, 2018: Investigator Spotlight Yousef Zakharia, MD, Holden Comprehensive Cancer Center at the University of Iowa Education background MD: Damascus University, Damascus, Syria Residency: University of Rochester Unity Hospital, Rochester, New York Fellowships: Michigan State University, Georgia Regents University (Medical College of Georgia) Research interests I am assistant professor of medicine in the division of medical oncology and hematology at the University of Iowa and medical oncologist at Holden Comprehensive Cancer Center. I specialize in melanoma and genitourinary malignancy. My research interests are...
July 26, 2018: Researchers and leaders from 12 Big Ten cancer centers will meet at Big Ten Conference Headquarters in Chicago on Saturday, Sept. 29. The Big Ten Cancer Research Consortium Summit is expected to draw about 150 participants, including researchers from across the consortium and representatives from pharmaceutical and biotech companies. The University of Wisconsin Carbone Cancer Center is hosting the meeting. Read More
July 15, 2018: The unified goal of the Big Ten cancer centers is improving the lives of all patients with cancer. In their union is the teamwork of 2,600 cancer researchers and 20,000 patient volunteers, all bringing unique perspectives and strengths to the multi-disciplinary mission. Every breakthrough, every grant, every life touched is a victory that belongs to us all. In the fight against cancer, the Big Ten Cancer Research Consortium stands as one. See why we are stronger together in this month's Across the Consortium! Read More
July 3, 2018: Investigator Spotlight David Peace, MD, University of Illinois Cancer Center Educational Background Medical School: University of Pittsburgh School of Medicine Residency: University of Pittsburgh School of Medicine Fellowship: University of Washington
Peace taking a shot at treating cancer Reprinted with permission from the University of Illinois Cancer Center newsletter Vaccines have been developed to fight the flu, combat chicken pox, and battle Hepatitis B. David Peace is working to add cancer to that list of diseases. Peace, MD, a member of the University of Illinois Cancer Center and professor of hematology and oncology at the...
June 19, 2018: Big Ten cancer centers are making strides and tackling some of the toughest questions in cancer research. In this month’s edition of Across the Consortium, we highlight advances in prostate cancer, breast cancer, head and neck cancer, multiple myeloma, bladder cancer, colorectal cancer, and new technologies and discoveries that could improve outcomes across many cancers. Behind these advances in research at Big Ten cancer centers are academic physicians and scientists who are not only brilliant in their fields, but also committed to research mentorship and disease prevention. Read More
June 6, 2018: Investigator Spotlight Emily Dykhuizen, PhD Purdue University Center for Cancer Research Educational Background BA, Reed College, Biochemistry and Molecular Biology PhD, UW-Madison, Chemistry Postdoc, Stanford University, Chromatin Biology Research Interests My lab works on understanding the role of chromatin regulation on cancer initiation and progression. More specifically, we look at how chromatin regulators regulate gene expression in response to environmental changes. From this information we outline how patient mutations found in chromatin regulators cooperate with the metabolic environment to promote cancer. We then develop strategies to inhibit these...
June 2, 2018: Two Big Ten Cancer Research Consortium studies were accepted as abstracts to the American Society of Clinical Oncology (ASCO) Annual Meeting, June 1-5, 2018, at the McCormick Place in Chicago. The BTCRC-GU14-003 study was presented during a poster session on Saturday, June 2, while the BTCRC-ESO14-012 study was accepted for publication. Arkadiusz Dudek, MD, PhD (left), is sponsor-investigator of BTCRC-GU14-003, and Shadia Jalal, MD, is sponsor-investigator of BTCRC-ESO14-012. BTCRC-GU14-003 was the Big Ten CRC's first study to open to accrual, and completed enrollment about six months ahead of schedule.
May 21, 2018: On your MARK, get SET, GO Across the Consortium! Get up to date on recent clinical trial outcomes; big leaps in funding; and diagnostic breakthroughs with far-reaching implications. Be inspired by the Big Ten CRC Member Institutions as you witness researchers tackling the toughest questions in oncology as a team. Read More
May 12, 2018: Investigator Spotlight Monika Joshi, MD, MRCP, Penn State Cancer Institute Educational Background MB, BS, Kasturba Medical College, Manipal Academy of Higher Education Member of Royal College of Physicians, London MD Residency, Internal Medicine, Pinnacle Health Hospitals Hematology/Oncology Fellowship, Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center Research Interests My clinical and research interests lie primarily in the field of genitourinary (GU) tumors, developing novel therapeutic combinations and biomarkers for GU cancer of the bladder, kidney and prostate. I have a keen interest in developing novel combination...
University of Illinois
Indiana University
University of Iowa
University of Maryland
University of Michigan
Michigan State
University of Minnesota
University of Nebraska
Northwestern University
Penn State University
Purdue University
Rutgers State University
University of Wisconsin
University of Illinois at Chicago
© 2024 All rights reserved.
Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube